digital health funding
British Growth Fund’s exit marks one of the largest for a UK medtech company and the most profitable return in the firm’s history.
The company plans to expand partnerships with health plans and employers to provide more individuals with digital twin technology designed to improve metabolic health.
The company will use the funds to expand EHR and PBM integrations and partner with digital health and other companies to expand medication access.
The company will use the newly garnered funds to scale its Medical-Grade AI offering.
The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac conditions and new distribution channels.
The company, which uses AI to help companies manage value-based care contracts, will use the funds to grow its team and scale its platform.
The funding comes a year after the company secured $70 million in a Series B funding round.
The funds will be used to grow the company's engineering and commercial workforce, enhance product development, and accelerate integration with payers and providers.
GenAI company for health plans Alaffia Health and oncology-focused clinical-trial platform Klineo also secured funding.
Pediatric chronic care company Clarity Pediatrics also secured $10 million in seed funding and Los Angeles-based Handl Health brought in $2.5M.